William A. Sullivan - Net Worth and Insider Trading
William A. Sullivan Net Worth
The estimated net worth of William A. Sullivan is at least $17,824 dollars as of 2024-12-14. William A. Sullivan is the CFO and Treasurer of Merrimack Pharmaceuticals Inc and owns about 1,100 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $16,643. William A. Sullivan is also the CFO of Applied Genetic Technologies Corp and owns about 3,000 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $1,181. Details can be seen in William A. Sullivan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William A. Sullivan has not made any transactions after 2018-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William A. Sullivan
William A. Sullivan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William A. Sullivan owns 2 companies in total, including Applied Genetic Technologies Corp (AGTC) , and Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of William A. Sullivan’s form 4 insider trades.
Insider Ownership Summary of William A. Sullivan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGTC | Applied Genetic Technologies Corp | 2018-12-14 | Chief Financial Officer |
| MACK | Merrimack Pharmaceuticals Inc | 2015-07-15 | CFO and Treasurer |
William A. Sullivan Latest Holdings Summary
William A. Sullivan currently owns a total of 2 stocks. Among these stocks, William A. Sullivan owns 1,100 shares of Merrimack Pharmaceuticals Inc (MACK) as of July 15, 2015, with a value of $16,643 and a weighting of 93.38%. William A. Sullivan also owns 3,000 shares of Applied Genetic Technologies Corp (AGTC) as of December 14, 2018, with a value of $1,181 and a weighting of 6.62%.
Latest Holdings of William A. Sullivan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2015-07-15 | 1,100 | 15.13 | 16,643 |
| AGTC | Applied Genetic Technologies Corp | 2018-12-14 | 3,000 | 0.39 | 1,181 |
Holding Weightings of William A. Sullivan
William A. Sullivan Form 4 Trading Tracker
According to the SEC Form 4 filings, William A. Sullivan has made a total of 0 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years. The most-recent trade in Merrimack Pharmaceuticals Inc is the sale of 1,500 shares on July 15, 2015, which brought William A. Sullivan around $177,750.
According to the SEC Form 4 filings, William A. Sullivan has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the acquisition of 3,000 shares on December 14, 2018, which cost William A. Sullivan around $9,990.
Insider Trading History of William A. Sullivan
- 1
William A. Sullivan Trading Performance
GuruFocus tracks the stock performance after each of William A. Sullivan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William A. Sullivan is 33.23%. GuruFocus also compares William A. Sullivan's trading performance to market benchmark return within the same time period. The performance of stocks bought by William A. Sullivan within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William A. Sullivan's insider trading performs compared to the benchmark.
Performance of William A. Sullivan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.31 | | | | | |
| Relative Return to S&P 500(%) | -3.64 | | | | | |
William A. Sullivan Ownership Network
Ownership Network List of William A. Sullivan
Ownership Network Relation of William A. Sullivan
William A. Sullivan Owned Company Details
What does Applied Genetic Technologies Corp do?
Who are the key executives at Applied Genetic Technologies Corp?
William A. Sullivan is the Chief Financial Officer of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .
Applied Genetic Technologies Corp (AGTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Genetic Technologies Corp Insider Transactions
William A. Sullivan Mailing Address
Above is the net worth, insider trading, and ownership report for William A. Sullivan. You might contact William A. Sullivan via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
